Group 1 - The stock price of Haitai Biotech experienced fluctuations on August 4, closing at 58.15 yuan, down 2.37% from the previous trading day [1] - The stock had a trading range of 10.17% on that day, with a transaction amount of 786 million yuan [1] - Haitai Biotech operates in the biopharmaceutical industry, focusing on the research, production, and sales of biological products, including innovative drugs and recombinant proteins [1] Group 2 - The company is actively monitoring the application and development of AI technology in the biopharmaceutical sector and will announce any significant developments in a timely manner [1] - On August 4, the net inflow of main funds was 18.58 million yuan, with a cumulative net inflow of 45.22 million yuan over the past five days [1]

证券日报网讯海特生物8月4日在互动平台回答投资者提问时表示，公司会积极关注AI技术在生物医药 方面的应用和发展，如有重大事项公司会及时公告。 （文章来源：证券日报） ...

证券之星消息，8月4日医疗服务板块较上一交易日下跌0.26%，昭衍新药领跌。当日上证指数报收于 3583.31，上涨0.66%。深证成指报收于11041.56，上涨0.46%。医疗服务板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | | 成交额(元) | | --- | --- | --- | --- | --- | --- | --- | | 688265 | 南模生物 | 43.73 | 20.01% | | 4.08万 | 1.66亿 | | 688621 | 阳光诺和 | 66.54 | 14.84% | | 12.60万 | 8.15亿 | | 301201 | 诚达药业 | 28.10 | 4.04% | | 10.58万 | 2.93亿 | | 688222 | 成都先导 | 24.74 | 3.82% | | 33.55万 | 7.91亿 | | 002172 | 澳洋健康 | 4.25 | 3.41% | | 70.07万 | 2.93亿 | | 688046 | 药康生物 | 16.41 | 3.01% | | 4.55万 | 7293.23万 | | ...

每经AI快讯，CRO概念股盘初震荡走低，奥翔药业跌超8%，海特生物跌超6%，美诺华、昭衍新药、泰 格医药跟跌。 ...

金融界8月4日消息，有投资者在互动平台向海特生物提问：贵司有结合AI大模型进行创新药研发吗？ 公司回答表示：尊敬的投资者，您好！公司会积极关注AI技术在生物医药方面的应用和发展，如有重 大事项公司会及时公告。谢谢！责任编辑：栎树 ...

Group 1 - The report maintains a strong market rating for the biopharmaceutical industry, particularly focusing on AAV gene therapy advancements in neurology and ophthalmology, highlighting companies such as Kanghong, TEBIO, and Hite [2][3][20] - AAV gene therapy has shown rapid development due to its unique properties, including small size, non-pathogenicity, and the ability to be engineered for various tissue targeting, making it a promising treatment for genetic diseases [10][11][14] - The report emphasizes the commercial success of AAV gene therapies, with notable products like Novartis' Zolgensma exceeding $1 billion in sales, indicating a growing market potential for common diseases [24][27] Group 2 - The report identifies key players in the AAV gene therapy space, including multinational corporations (MNCs) like Sanofi, Bayer, and Roche, which are actively developing pipelines targeting CNS, ophthalmology, and metabolic diseases [20][33] - It highlights the ongoing clinical trials and advancements in AAV gene therapies for common diseases, particularly in the CNS and ophthalmology sectors, with a focus on the potential of new AAV vectors to cross the blood-brain barrier [35][37] - The report suggests that domestic companies such as Kanghong, TEBIO, and Hite are well-positioned in the AAV gene therapy landscape, with diverse and rapidly progressing pipelines [42]

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300149 | 睿智医药 | 13.30 | -6.60% | 97.13万 | 13.47 乙 | | 688710 | 益诺思 | 42.93 | -4.34% | 2.77万 | 1.21亿 | | 300725 | 药石科技 | 47.25 | -4.08% | 22.57万 | 10.92亿 | | 603456 | 九州药业 | 18.32 | -3.48% | 63.91万 | 11.90亿 | | 603259 | 药明康德 | 93.00 | -3.40% | 89.33万 | 83.98亿 | | 300759 | 康龙化成 | 30.10 | -3.22% | 61.22万 | 18.70亿 | | 688202 | 美迪西 | 61.60 | -2.84% | 7.28万 | 4.55 Z | | 002173 | 创新医疗 | 14.92 | -2.74% | 81.94万 | 12.53亿 | | 002821 | 司 ...

格隆汇8月1日丨海特生物(300683.SZ)于投资者互动平台表示，公司会与专业的国际咨询机构合作积极 推进创新药的出海工作，目前暂无创新药出海业务。 ...

天眼查商业履历信息显示，武汉海特生物制药股份有限公司，成立于1992年，位于武汉市，是一家以从 事医药制造业为主的企业。企业注册资本13089.4391万人民币，实缴资本1592.3561万人民币。公司法定 代表人为陈亚。 通过天眼查大数据分析，武汉海特生物制药股份有限公司共对外投资了16家企业，参与招投标项目98 次，知识产权方面有商标信息57条，专利信息11条，此外企业还拥有行政许可56个。 金融界消息 截至2025年7月31日收盘，海特生物（300683）报收于56.33元，上涨8.37%，换手率 14.7%，成交量17.94万手，成交金额10.12亿元。 资金流向方面，今日主力资金净流入2577.65万元，占比成交额2.55%。其中，超大单净流入2235.12万 元、占成交额2.21%，大单净流入342.53万元、占成交额0.34%，中单净流出流出1482.86万元、占成交 额1.46%，小单净流出1094.79万元、占成交额1.08%。 海特生物最新一期业绩显示，截至2025一季报，公司营业总收入1.57亿元、同比增长18.79%，归属净利 润1393.04万元，同比增长15.81%，扣非净利润17 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 300683 | 海特生物 | 56.33 | 8.37% | 17.94万 | | 10.12亿 | | 002173 | 创新医疗 | 15.34 | 7.72% | 76.57万 | | 11.37亿 | | 301096 | 百诚医药 | 58.45 | 7.09% | 17.58万 | | 10.01亿 | | 000710 | 贝瑞基因 | 14.64 | 4.95% | 56.75万 | | 8.30亿 | | 301293 | 三博脑科 | 50.08 | 3.58% | 14.57万 | | 7.19 Z | | 300149 | 睿智医药 | 14.24 | 3.56% | 134.38万 | | 18.69亿 | | 000504 | *ST生物 | 10.67 | 3.39% | 5.73万 | | 6098.79万 | | 300244 | 迪安诊断 | 16.10 | 1.58% | 37.94万 | | ...